Stay updated on Emicizumab Prophylaxis in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Emicizumab Prophylaxis in Hemophilia A Clinical Trial page.

Latest updates to the Emicizumab Prophylaxis in Hemophilia A Clinical Trial page
- CheckyesterdayChange DetectedA sitewide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the previous content with an access-restricted message. A Home link is displayed, indicating the resource cannot be viewed at this time.SummaryDifference21%

- Check57 days agoChange DetectedAdded 2016 ( U.S. NIH Grant/Contract ) to the study's identifiers. Updated the revision metadata from v3.6.5 to v3.6.6, and removed the prior v3.6.5 reference.SummaryDifference0.1%

- Check78 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a minor update to the study page. No substantive changes to the study details or sections are indicated.SummaryDifference0.0%

Stay in the know with updates to Emicizumab Prophylaxis in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emicizumab Prophylaxis in Hemophilia A Clinical Trial page.